| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/12/2010 | US7811791 nucleic acid ; for diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IFN-L polypeptides |
| 10/12/2010 | US7811789 Expression vector comprising nucleotide sequences coding migration stimulation factor for use in identifying modulator for treatment and prevention of cell proliferative disorders; wound healing agents |
| 10/12/2010 | US7811782 drug screening for cardiovascular diseases by cultures; applying hemodynamic shear stress patterns to human/animal cells in culture |
| 10/12/2010 | US7811781 comparing the level of Core 2 GlcNAc-T enzyme activity in a blood sample from a subject with a control; biomarker |
| 10/12/2010 | US7811780 Method for measurement of cholesterol in high-density lipoprotein |
| 10/12/2010 | US7811779 stabilizing a reagent that allows simultaneous quantification of LDL cholesterol and total cholesterol by a single measurement by suppressing spontaneous color development |
| 10/12/2010 | US7811767 Methods and compositions for assessing acute rejection |
| 10/12/2010 | US7811766 A pair of oligonucleotide molecules for amplification of ribosomal DNA from a plant material; DNA polymerase chain reaction |
| 10/12/2010 | US7811765 Methods and compositions for determining predisposition to inflammation-mediated cardiovascular disease |
| 10/12/2010 | US7811764 Hybridization-based biosensor containing hairpin probes and use thereof |
| 10/12/2010 | US7811763 Oligonucleotide probes for the genomic typifying of erythrocyte systems, methods and relative diagnostic kits |
| 10/12/2010 | US7811762 identifying polymorphisms associated with hereditary spastic paraplegia; specific mutations in the receptor expression enhancing protein 1 (REEP1) gene; neurodegenerative diseases |
| 10/12/2010 | US7811761 Method for identifying progressive rod-cone degeneration in dogs |
| 10/12/2010 | US7811760 Vector and method for detecting the change in transcription amount |
| 10/12/2010 | US7811759 Method for detecting ncRNA |
| 10/12/2010 | US7811758 Using apparatus comprising adsorbent solid phase to recover nucleotide sequences from specimen fluids; DNA recovery |
| 10/12/2010 | US7811757 Using shed cellular material as evaluative indicator of cell proliferative disorders |
| 10/12/2010 | US7811755 Methods and articles for strand-specific polynucleotide detection with cationic multichromophores |
| 10/12/2010 | US7811754 plurality of wildtype and SNP probes are immobilized on a planar waveguide, a fluorescently labeled analyte is then flowed over the planar waveguide, binding of the analyte to the wildtype and SNP probes is detected in real-time and the hybridization kinetics are compared |
| 10/12/2010 | US7811753 Methods for repairing degraded DNA |
| 10/12/2010 | US7811752 detecting non-clinically diagnosed cancer by extracting blood serum or plasma from the patient, and then detecting beta-catenin RNA in the blood serum or plasma; colorectal cancer; noninvasive and improved accessibility of sample collections and sensitivity |
| 10/12/2010 | US7811751 Labeling hybrid oligonucleotides; immobilization; sequence determination |
| 10/12/2010 | US7811750 Using soluble frizzled related protein 3 (SFRP-3) and/or Dickkopf-1 (DKK1) expression profiles as evaluative tools in prediciting/diagnosing bone disorders in cancer patients |
| 10/12/2010 | US7811588 Therapeutic agent for treatment and prevention of bacterial infections; immunoassay |
| 10/12/2010 | US7811577 Covalently stabilized chimeric coiled-coil HIV gp41 N-peptides with improved antiviral activity |
| 10/12/2010 | US7811571 Binding polyallylamine with signal molecules having a functional group, purification, binding the purified protein, antibody, antigen nucleic acid capture agents to form a conjugate |
| 10/12/2010 | US7811569 Recombinant anti-Plasmodium falciparum antibodies |
| 10/12/2010 | CA2497818C Glyt1 transgenic mice |
| 10/12/2010 | CA2422752C Map-based genome mining method for identifying regulatory loci controlling the level of gene transcripts and products |
| 10/12/2010 | CA2367468C Rheumatoid arthritis gene and method for diagnosing rheumatoid arthritis |
| 10/12/2010 | CA2358992C Method for controlling the extension of an oligonucleotide |
| 10/12/2010 | CA2341581C Fast measuring device of enzymatic activity |
| 10/12/2010 | CA2341268C Streptococcus suis vaccines and diagnostic tests |
| 10/12/2010 | CA2300176C Latent reactive polymers with biologically active moieties |
| 10/12/2010 | CA2282793C Non-invasive prenatal diagnosis |
| 10/12/2010 | CA2270023C Improved methods for extracting nucleic acids from tissue samples and paraffin-embedded tissues |
| 10/12/2010 | CA2245494C Human c-ha-ras proto-oncogene transgenic rat |
| 10/12/2010 | CA2244735C Method of managing the chemotherapy of patients who are hiv positive based on the phenotypic drug sensitivity of human hiv strains |
| 10/09/2010 | CA2701013A1 Markers associated with resistance to aphis glycines and methods of use therefor |
| 10/09/2010 | CA2699161A1 Dye composition for fluid transfer control |
| 10/09/2010 | CA2699011A1 Fluid transfer control |
| 10/09/2010 | CA2691714A1 Determination of 5-asa efficacy in crc prevention and/or treatment by gene expression analysis |
| 10/07/2010 | WO2010115167A2 Methods and devices for sorting cells and other biological particulates |
| 10/07/2010 | WO2010115160A2 Devices and methods for heating biological samples |
| 10/07/2010 | WO2010115154A1 Multi-primer amplification method for barcoding of target nucleic acids |
| 10/07/2010 | WO2010115147A2 Biomolecular sensing with metal-nanostructures |
| 10/07/2010 | WO2010115127A1 Use of id4 for diagnosis and treatment of cancer |
| 10/07/2010 | WO2010115122A2 Generation of uniform fragments of nucleic acids using patterned substrates |
| 10/07/2010 | WO2010115119A2 Compositions and methods for diagnosis and prognosis of cancer and progression, and for screening anti-cancer agents |
| 10/07/2010 | WO2010115100A1 Multiplex nucleic acid detection methods and systems |
| 10/07/2010 | WO2010115092A2 Compositions and methods for treating or preventing inflammatory bowel disease and colon cancer |
| 10/07/2010 | WO2010115061A2 Biomarkers for monitoring treatment of neuropsychiatric diseases |
| 10/07/2010 | WO2010115044A2 Selective tagging of short nucleic acid fragments and selective protection of target sequences from degradation |
| 10/07/2010 | WO2010115025A2 Device and methods for isolating cells |
| 10/07/2010 | WO2010115024A1 Detection of infectious disease in a human or animal by measuring specific phagocytosis in a thin film sample of their anticoagulated blood |
| 10/07/2010 | WO2010115016A2 Nucleic acid preparation compositions and methods |
| 10/07/2010 | WO2010114979A2 Radiation therapy biomarkers |
| 10/07/2010 | WO2010114922A1 Methods of treating cancer having an aberrant egfr or kras genotype |
| 10/07/2010 | WO2010114912A1 Minimally invasive assessment of ige mediated allergy |
| 10/07/2010 | WO2010114897A1 Biomarkers related to insulin resistance and methods using the same |
| 10/07/2010 | WO2010114842A1 Bioagent detection systems, devices, and methods |
| 10/07/2010 | WO2010114821A1 Genomic dna methylation analysis |
| 10/07/2010 | WO2010114772A2 Biological and chemical collection and detection |
| 10/07/2010 | WO2010114686A2 Modulation of abcg2-mediated urate transport to treat hyperuricemia and gout |
| 10/07/2010 | WO2010114599A1 Chemical ligation dependent probe amplification (clpa) |
| 10/07/2010 | WO2010114554A1 Hmgn3 for detecting and treating diabetes |
| 10/07/2010 | WO2010114375A1 Method for determination of unknown mutations |
| 10/07/2010 | WO2010114361A1 Method for determination of one or more mutations |
| 10/07/2010 | WO2010114193A1 Isolation method for inner cell masses and method for preparing embryonic stem cell lines using the same |
| 10/07/2010 | WO2010114188A1 Method for providing information on antidepressant therapeutic effect using single nucleotide polymorphism |
| 10/07/2010 | WO2010114037A1 Method for identification of metallo-β-lactamase-producing bacterium |
| 10/07/2010 | WO2010113959A1 Sample analysis chip, sample analyzer using sample analysis chip, sample analysis method, and method of producing sample analysis chip |
| 10/07/2010 | WO2010113789A1 Method for designing primer for selex method, method for producing primer, method for producing aptamer, device for designing primer, and computer program and recording medium for designing primer |
| 10/07/2010 | WO2010113627A1 Highly sensitive detection method for highly virulent oral cavity bacteria |
| 10/07/2010 | WO2010113529A1 Method for detection of colorectal tumor |
| 10/07/2010 | WO2010113495A1 C6orf167 peptides and vaccines containing the same |
| 10/07/2010 | WO2010113452A1 Method of distinguishing genotypes |
| 10/07/2010 | WO2010113185A1 Genetic markers for risk management of atrial fibrillation and stroke |
| 10/07/2010 | WO2010113096A1 Methods of predicting clinical course and treating multiple sclerosis |
| 10/07/2010 | WO2010113088A1 Methylation ligation-dependent macroarray (mlm) |
| 10/07/2010 | WO2010113034A2 Genotyping for risk of atherosclerosis |
| 10/07/2010 | WO2010112935A1 Diagnostic test for virus |
| 10/07/2010 | WO2010112840A1 A method for in vitro molecular evolution of protein function |
| 10/07/2010 | WO2010112833A1 Electrochemical test device |
| 10/07/2010 | WO2010112821A1 Genotoxicity testing |
| 10/07/2010 | WO2010112576A1 Means and methods of sterilization of biofunctional compositions |
| 10/07/2010 | WO2010112569A1 Modulation of adipose triglyceride lipase for prevention and treatment of cachexia, loss of weight and muscle atrophy and methods of screening therefor |
| 10/07/2010 | WO2010112316A1 Method for diagnosis of cancer and monitoring of cancer treatments |
| 10/07/2010 | WO2010112210A1 Methods for the identification of kinase interacting molecules and for the purification of kinase proteins |
| 10/07/2010 | WO2010112033A2 Method for estimating the risk of having or developing multiple sclerosis using sequence polymorphisms in a specific region of chromosome x |
| 10/07/2010 | WO2010111891A1 Modified oligo-nucleic acid molecule, preparation method and uses thereof |
| 10/07/2010 | WO2010111883A1 Method for testing drug sensitivity and device thereof |
| 10/07/2010 | WO2010111776A1 Method and system for multiple nucleic acid amplification and quantitation |
| 10/07/2010 | WO2010092266A3 Statistical genetic amplification for the preconception-free identification of microorganisms by sequencing without any cloning step |
| 10/07/2010 | WO2010085966A3 Method for quantification of small rna species |
| 10/07/2010 | WO2010083392A3 Ets-2 biomarkers for fibrotic diseases and uses thereof |
| 10/07/2010 | WO2010080702A3 Gene expression profiling for the identification, monitoring, and treatment of prostate cancer |
| 10/07/2010 | WO2010080582A3 Molecular assay for diagnosis of hiv tropism |
| 10/07/2010 | WO2010076788A3 Methods of predicting responsiveness to interferon treatment and treating hepatitis c infection |
| 10/07/2010 | WO2010075414A3 Method for detection of xmrv |